Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:RXDX’

13G Filing: Cormorant Asset Management and Ignyta Inc. (RXDX)

Ignyta Inc. (NASDAQ:RXDX): Bihua Chen’s Cormorant Asset Management filed an amended 13D. You can check out Cormorant Asset Management’s latest......(read more)
Biopharmaceutical, Bio-technology

Opus Point Partners’ AUM, History and Investments

Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr. Rosenwald......(read more)
Wall Street Stocks Market Insider Trading

32 Major Stories Summarizing What’s Happening in the World of Finance Today

1. U.S. Stock Market: “The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high......(read more)

13G Filing: Cephalon Inc and Ignyta Inc. (NASDAQ:RXDX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 6 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
researcher, research, background, medical, health, test, chemistry, experiment, equations, technician, table, reaction, pharmaceutical, periodic, liquid, dropper, tool, bio, discovery

Is Ignyta Inc (RXDX) A Good Stock To Buy?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Ignyta Inc. (RXDX): Great Point Partners Reports New Stake

In a recent 13G filing with the US SEC, Jeffrey Jay and David Kroin‘s Great Point Partners reported the acquisition of 2.05 million shares of  ......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

One Vehicle-Repair Giant and Two Biotech Companies with Clusters of Insider Buying

The insider trading activity decreased quite significantly last week as compared to the activity observed during the previous one, partially owing to......(read more)
pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat

Is Ignyta Inc (RXDX) A Good Stock To Buy?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the......(read more)
Michael Castor of Sio Capital

Healthcare-Focused Investor Believes These Three Cheap Stocks are Poised to Explode

September was one of the worst periods for healthcare stocks and the returns of healthcare-focused investors suffered a lot amid an 11% drop in the NASDAQ......(read more)
Jim Tananbaum - Foresite Capital

Foresite Capital Betting It All On These Four Healthcare Stocks

Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing......(read more)
Broadfin Kevin Kotler

Ignyta Inc, Horizon Pharma PLC: Biotech Hedgie Kevin Kotler Enjoys Strong Gains

Kevin Kotler‘s Broadfin Capital has disclosed raising its passive stake in the micro-cap oncology biotechnology company Ignyta Inc (NASDAQ:RXDX).......(read more)